# ImpactLife – FDA Inspection, Jul 18, 2017

Source: https://www.keypedia.com/records/fda_inspections/impactlife/a78a55a8-8e4d-4695-8d0d-bd3e9d3b1521
Source feed: FDA_Inspections

> FDA inspection 1026192 of ImpactLife, July 18, 2017. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1026192
- Company Name: ImpactLife
- Inspection Date: 2017-07-18
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1274630 - 2025-07-03](https://www.keypedia.com/records/fda_inspections/impactlife/8f57693f-a1d8-4fed-9d81-69de6e1fbea1)
- FDA Inspection 1106877 - 2019-09-12
- FDA Inspection 921394 - 2015-03-26
- [FDA Inspection 828694 - 2013-05-01](https://www.keypedia.com/records/fda_inspections/impactlife/57b874e2-edda-4f81-bab3-ae224e280e7d)
- FDA Inspection 700491 - 2010-12-07

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/amy-w-yan-mai/00551315-3a03-4327-ab3a-71de5c1577d4)

Company: https://www.keypedia.com/companies/impactlife/4a069fdf-ff53-49b2-b830-1f43d195d28e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
